94 related articles for article (PubMed ID: 22445758)
1. A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function.
Takata A; Otsuka M; Yoshikawa T; Kishikawa T; Kudo Y; Goto T; Yoshida H; Koike K
Biochem Biophys Res Commun; 2012 Apr; 420(3):564-9. PubMed ID: 22445758
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression.
Takata A; Otsuka M; Yoshikawa T; Kishikawa T; Hikiba Y; Obi S; Goto T; Kang YJ; Maeda S; Yoshida H; Omata M; Asahara H; Koike K
Hepatology; 2013 Jan; 57(1):162-70. PubMed ID: 22898998
[TBL] [Abstract][Full Text] [Related]
3. High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.
Chen W; Zhou P; Li X
Int J Mol Med; 2016 Jun; 37(6):1551-7. PubMed ID: 27121695
[TBL] [Abstract][Full Text] [Related]
4. Human bone mesenchymal stem cells-derived exosomal miRNA-361-5p alleviates osteoarthritis by downregulating DDX20 and inactivating the NF-κB signaling pathway.
Tao Y; Zhou J; Wang Z; Tao H; Bai J; Ge G; Li W; Zhang W; Hao Y; Yang X; Geng D
Bioorg Chem; 2021 Aug; 113():104978. PubMed ID: 34052737
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators.
Takata A; Otsuka M; Kojima K; Yoshikawa T; Kishikawa T; Yoshida H; Koike K
Biochem Biophys Res Commun; 2011 Aug; 411(4):826-31. PubMed ID: 21798241
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
9. DDX20: A Multifunctional Complex Protein.
He L; Yang J; Hao Y; Yang X; Shi X; Zhang D; Zhao D; Yan W; Bie X; Chen L; Chen G; Zhao S; Liu X; Zheng H; Zhang K
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894677
[TBL] [Abstract][Full Text] [Related]
10. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
Kim HS; Chang I; Kim JY; Choi KH; Lee MS
Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.
Wang X; Jiang F; Mu J; Ye X; Si L; Ning S; Li Z; Li Y
Toxicol Lett; 2014 Jun; 227(2):75-83. PubMed ID: 24680928
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D3 upregulated protein 1 suppresses TNF-α-induced NF-κB activation in hepatocarcinogenesis.
Kwon HJ; Won YS; Suh HW; Jeon JH; Shao Y; Yoon SR; Chung JW; Kim TD; Kim HM; Nam KH; Yoon WK; Kim DG; Kim JH; Kim YS; Kim DY; Kim HC; Choi I
J Immunol; 2010 Oct; 185(7):3980-9. PubMed ID: 20826751
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways.
Zhang L; Yang L; Liu X; Chen W; Chang L; Chen L; Loera S; Chu P; Huang WC; Liu YR; Yen Y
Hepatology; 2013 May; 57(5):1919-30. PubMed ID: 23175432
[TBL] [Abstract][Full Text] [Related]
15. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
16. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential.
Hsiang CY; Wu SL; Chen JC; Lo HY; Li CC; Chiang SY; Wu HC; Ho TY
Toxicol Lett; 2007 Jun; 171(1-2):78-86. PubMed ID: 17543481
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress enhances AP-1 and NF-κB-mediated regulation of β(2)-glycoprotein I gene expression in hepatoma cells.
Chiu WC; Chen CJ; Lee TS; Chen ZJ; Ke PH; Chiang AN
J Cell Biochem; 2010 Nov; 111(4):988-98. PubMed ID: 20665665
[TBL] [Abstract][Full Text] [Related]
18. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
20. Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells.
Liang JA; Wu SL; Lo HY; Hsiang CY; Ho TY
Mol Pharmacol; 2009 Jan; 75(1):151-7. PubMed ID: 18835982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
